Beigene Stock Beta
| B1GN34 Stock | BRL 42.30 1.46 3.34% |
BeiGene fundamentals help investors to digest information that contributes to BeiGene's financial success or failures. It also enables traders to predict the movement of BeiGene Stock. The fundamental analysis module provides a way to measure BeiGene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BeiGene stock.
BeiGene |
BeiGene Company Beta Analysis
BeiGene's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current BeiGene Beta | 0.72 |
Most of BeiGene's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BeiGene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, BeiGene has a Beta of 0.7197. This is 16.31% lower than that of the Healthcare sector and 48.22% lower than that of the Biotechnology industry. The beta for all Brazil stocks is notably lower than that of the firm.
BeiGene Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BeiGene's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics of similar companies.BeiGene is rated fourth in beta category among its peers.
As returns on the market increase, BeiGene's returns are expected to increase less than the market. However, during the bear market, the loss of holding BeiGene is expected to be smaller as well.
BeiGene Fundamentals
| Return On Equity | -0.53 | |||
| Return On Asset | -0.2 | |||
| Profit Margin | (1.68) % | |||
| Operating Margin | (1.52) % | |||
| Current Valuation | 93.43 B | |||
| Shares Outstanding | 1.35 B | |||
| Price To Book | 2.09 X | |||
| Price To Sales | 92.86 X | |||
| Revenue | 1.18 B | |||
| Gross Profit | (447.86 M) | |||
| EBITDA | (1.39 B) | |||
| Net Income | (1.41 B) | |||
| Total Debt | 202.11 M | |||
| Book Value Per Share | 44.84 X | |||
| Cash Flow From Operations | (1.3 B) | |||
| Earnings Per Share | (19.92) X | |||
| Number Of Employees | 9 K | |||
| Beta | 0.72 | |||
| Market Capitalization | 134.44 B | |||
| Total Asset | 8.65 B | |||
| Net Asset | 8.65 B |
About BeiGene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in BeiGene Stock
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.